Information Library

Results for: Demonstrating Value - Product Development & Commercialization

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Reinventing Biopharma

    White Paper — February 1, 2012
    The biopharmaceutical industry today is facing a multifaceted “value challenge.”

  • New Healthcare Architecture to Maximize Vaccine Coverage Rates

    Hear from the Experts — April 19, 2011
    Jason Baumgartner discusses the steps required to create a complete healthcare architecture the shift among biopharma toward preventive medicine.

  • Podcast: Biopharma's Commercialization Challenges

    Hear from the Experts — April 19, 2010
    Michael Ackermann, Ph.D., Vice President of Global Commercial Strategy and Alliance, Global Commercial Solutions at Quintiles, discusses the factors that are leading to a radical shift in how biopharmaceutical products are developed and commercialized.

  • Rewarding Innovation and Value

    White Paper — October 6, 2009
    The impact of comparative effectiveness research on the future of drug development.

  • Podcast: A New Gold Standard

    Hear from the Experts — May 1, 2008
    John Doyle discusses the concept of a health economic balance sheet and the need for evidence-based pricing for biopharmaceutical valuation.

Page 1 of 1 (5 results)

Subscribe to Email Based on Your Interests

Set preferences